Pasman, Joëlle A. http://orcid.org/0000-0001-7558-0482
,
Verweij, Karin J. H.
Gerring, Zachary
Stringer, Sven http://orcid.org/0000-0003-3115-8532
Sanchez-Roige, Sandra
Treur, Jorien L.
Abdellaoui, Abdel
Nivard, Michel G. http://orcid.org/0000-0003-2015-1888
Baselmans, Bart M. L.
Ong, Jue-Sheng http://orcid.org/0000-0002-6062-710X
Ip, Hill F. http://orcid.org/0000-0003-1991-5019
van der Zee, Matthijs D.
Bartels, Meike http://orcid.org/0000-0002-9667-7555
Day, Felix R. http://orcid.org/0000-0003-3789-7651
Fontanillas, Pierre
Elson, Sarah L.
de Wit, Harriet
Davis, Lea K. http://orcid.org/0000-0001-5143-2282
MacKillop, James http://orcid.org/0000-0003-4118-9500
Derringer, Jaime L.
Branje, Susan J. T.
Hartman, Catharina A.
Heath, Andrew C.
van Lier, Pol A. C.
Madden, Pamela A. F.
Mägi, Reedik
Meeus, Wim
Montgomery, Grant W. http://orcid.org/0000-0002-4140-8139
Oldehinkel, A. J. http://orcid.org/0000-0003-3925-3913
Pausova, Zdenka
Ramos-Quiroga, Josep A.
Paus, Tomas
Ribases, Marta http://orcid.org/0000-0003-1039-1116
Kaprio, Jaakko http://orcid.org/0000-0002-3716-2455
Boks, Marco P. M. http://orcid.org/0000-0001-6163-7484
Bell, Jordana T.
Spector, Tim D.
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Boomsma, Dorret I.
Martin, Nicholas G.
MacGregor, Stuart http://orcid.org/0000-0001-6731-8142
Perry, John R. B.
Palmer, Abraham A. http://orcid.org/0000-0003-3634-0747
Posthuma, Danielle http://orcid.org/0000-0001-7582-2365
Munafò, Marcus R. http://orcid.org/0000-0002-4049-993X
Gillespie, Nathan A.
Derks, Eske M. http://orcid.org/0000-0002-6292-6883
Vink, Jacqueline M. http://orcid.org/0000-0003-3910-3528
,
,
Article History
Received: 12 January 2018
Accepted: 28 May 2018
First Online: 27 August 2018
Change Date: 5 June 2019
Change Type: Correction
Change Details: Several occurrences of the word ‘schizophrenia’ have been re-worded as ‘liability to schizophrenia’ or ‘schizophrenia risk’, including in the title, which should have been “GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability,” as well as in Supplementary Figures 1–10 and Supplementary Tables 7–10, to more accurately reflect the findings of the work.
Competing interests
: P.F., S.L.E. and members of the 23andMe Research Team are employees of 23andMe Inc. J.A.R.-Q. was on the speakers’ bureau and/or acted as consultant for Eli Lilly, Janssen-Cilag, Novartis, Shire, Lundbeck, Almirall, BRAINGAZE, Sincrolab and Rubió in the last 5 years. He also received travel awards (air tickets and hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire and Eli Lilly. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last 5 years: Eli Lilly, Lundbeck, Janssen- Cilag, Actelion, Shire, Ferrer and Rubió.